Acquisition - July 9, 2025
Alvotech acquires Ivers-Lee Group in Switzerland
Alvotech has announced the expansion of its capacity for assembly and packaging with the acquisition of Ivers-Lee Group, a family owned business with headquarters in Burgdorf, Switzerland specializing in providing assembly and packaging services for the pharmaceutical sector.
Agreement - July 2, 2025
Alvotech and Advanz Pharma enter agreement
The companies have entered into a supply and commercialization agreement for AVT10, Alvotech’s biosimilar candidate to Cimzia (certolizumab pegol).
Biotech Business - July 2, 2025
Pixelgen awarded USD 14.7 million in blended funding
The company has been awarded grant and equity financing from the European Innovation Council (EIC) Accelerator, a funding initiative under the European Union's Horizon Europe program designed to support highly innovative start-ups with disruptive technologies.
Biotech Business - June 25, 2025
Evaxion expands its R&D pipeline with new vaccine program
Evaxion initiates work to develop a new preventive vaccine against Group A Streptococcus (GAS).
Biotech Business - June 25, 2025
Qlucore receives approval for EUR 0.5 million installment from the EU
The aim of the project is to accelerate the development of clinical cancer diagnostics solutions for acute myeloid leukemia (AML) as well as bladder cancer.
Biotech Business - June 24, 2025
Cereno Scientific secures SEK 100 million
Cereno Scientific has announced entering loan financing agreements.
